Results 71 to 80 of about 4,182 (143)

Pfizer-BioNTech COVID-19 vaccine : standing orders for administering vaccine to persons 12 years of age and older [PDF]

open access: yes
To reduce morbidity and mortality from coronavirus disease 2019 (COVID-19) by vaccinating persons who meet the criteria established by the Centers for Disease Control and Prevention\u2019s Advisory Committee on Immunization Practices (ACIP).CS321570 ...

core  

Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12\u201317 Years \u2014 U.S. December 9, 2021\u2013February 20, 2022

open access: yes
What is already known about this topic? Adults aged 6518 years reported adverse reactions less frequently after receipt of a homologous Pfizer-BioNTech COVID-19 booster dose than after the second primary dose.What is added by this report?

core  

Pfizer-BioNTech COVID-19 vaccine (purple cap) age 12 and over : standing orders for administering vaccine

open access: yes
To reduce morbidity and mortality from coronavirus disease 2019 (COVID-19) by vaccinating persons who meet the criteria established by the Centers for Disease Control and Prevention\u2019s Advisory Committee on Immunization Practices (ACIP).CS321570 ...

core  

COVID-19 mRNA bivalent booster vaccine safety

open access: yes
COVID-02-Shimabukuro-508 ...

core  

COVID-19 Vaccines Breakthrough Infections and Adverse Effects Reported by the Birzeit University Community in Palestine

open access: yesInternational Journal of General Medicine
Abdallah Damin Abukhalil,* Raya Riyad Abushehadeh,* Sireen Sultan Shatat,* Ni’meh Al-Shami,* Hani A Naseef,* Hosniyeh Ladadweh,* Raed Madia* Faculty of Pharmacy, Nursing and Health Professions, Birzeit University, Birzeit ...
Abukhalil AD   +6 more
doaj  

Home - About - Disclaimer - Privacy